⏳ Fetching live dividend data...
Home › Calculator › IPCIF Dividend Calculator 2026
Intellipharmaceutics International Inc. · OTC
Price: $0.15 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
IPCIF is not a dividend-focused stock
IPCIF pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Intellipharmaceutics International Inc. (IPCIF) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
Intellipharmaceutics International Inc. operates as a pharmaceutical firm primarily engaged in the research, development, and manufacturing of both novel and generic oral solid dosage medications that feature controlled and targeted release mechanisms. The company's U.S. operations are central to its work. Leveraging its unique and patented Hypermatrix technology, Intellipharmaceutics is dedicated to creating advanced drug delivery systems and cultivating a robust pipeline of product candidates across various therapeutic domains. These include critical areas such as neurological disorders, cardiovascular health, gastrointestinal conditions, diabetes, and pain management. The company's current commercial portfolio includes a variety of extended-release and delayed-release products. These offerings address conditions like hyperactivity disorder (Focalin XR), epilepsy (Keppra XR, Lamictal XR), depression (Effexor XR, Pristiq, Seroquel XR), gastroesophageal reflux disease (Protonix), type 2 diabetes (Glucophage XR), schizophrenia and bipolar disorder (Seroquel XR), heart failure and hypertension (Coreg CR), and chronic angina (Ranexa). Additionally, Intellipharmaceutics is actively progressing several developmental compounds, such as an oxycodone hydrochloride controlled-release capsule (OxyContin) for pain management and a pregabalin extended-release capsule (Regabatin XR) designed for neuropathic pain. The company has established a licensing and commercialization partnership with Par Pharmaceutical Inc. Established in 1998, Intellipharmaceutics International Inc. is based in Toronto, Canada.
No. Intellipharmaceutics International Inc. (IPCIF) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
A DRIP reinvests dividends into new shares. IPCIF has no regular dividend in our data, so there is nothing to reinvest.
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open IPCIF position with:
Real after-tax yield depends on where you live and how you hold IPCIF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
IPCIF pays quarterly — 4 times per year. Ex-div: —.
How IPCIF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IPCIF sourced from FMP /financial-growth endpoint — real data, not estimates.
Compare IPCIF with peers: IPCIF vs ACRDF · IPCIF vs ACRHF · IPCIF vs BRRGF
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IPCIF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Intellipharmaceutics International Inc. (IPCIF) is currently trading at $0.15, trading near its 52-week high. It does not currently pay a regular dividend.
Intellipharmaceutics International Inc. (IPCIF) is a healthcare stock trading at $0.15. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
Auto-generated from live market data. For educational purposes only — not financial advice.
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever